Current Issue
Launching a Biological Drug in China: From Biosimilar to Innovative Molecules Key Consider...
Joe X Zhou, Ph.D., CEO Genor BioPharma Jinhai Shi, Ph.D., General Secretary China Protei...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Principal Scientist Janssen R&D
Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Co...
Thorsten Lorenz, PhD, Head Developability Assessment Thomas Jostock, PhD, Science and Te...
Raw Material Qualification – A Practical Approach
Aurora Henry, Biopharmaceutical Professional CMC Biologics
Keys to Successful Implementation of Single-Use Technology
How and why collaboration improves single-use products Willem Kools, PhD., Head of Technol...
How To Select The Right Filter Integrity Test Instrument
Pall Biotech
Featured Articles
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
View All Featured ArticlesHeadline News
Suven Life Sciences secures Product Patents in India, Singapore, South Korea and Israel
NATCO launches fixed dose combination of Sofosbuvir-Daclatasvir drug for Hepatitis C treatment in INDIA
Glenmark Pharmaceuticals Announces Exclusive Licensing Agreement with Seqirus for its Investigational Seasonal Allergic Rhinitis Nasal Spray – Ryaltris
Read All Headlines
Upcoming Webinars
Challenges in the Development of Continuous Processes for Vaccines
Presented by Danny Vellom of Sanofi Pasteur Biologics, Inc.
04th March 2019
Developability Assessment of Therapeutic Proteins – A Toolbox for Tackling Increasing Complexity
Presented by Thorsten Lorenz, Team Head Developability Assessment Biologics, Novartis
27th September 2018
Lifecycle management of single use technologies
Presented by Francis Verhoeye, Director Single Use Technologies, GSK Vaccines
05th March 2019
View All Upcoming Webinars
Past Webinars
Mass Spectrometry – an Essential Tool for Characterization of Monoclonal Antibodies during Development
Presented by Dr Wei Xu & Dr Henry Shion
03rd February 2016
Patient-Centric Drug Delivery Strategies For Oral Paediatric Products
Presented by Dr. Carsten Timpe and Dr. Paolo Gatti
22nd April 2015
Development and Manufacturing of Recombinant Nanoparticle Vaccines
Presented by Atin Tomar, President & CEO, CPL Biologicals Pvt. & Amélie Boulais, Vaccine Platform Marketing Manager, Sartorius Stedim Biotech
12th July 2018
View All Past Webinars
Featured Companies
View All Companies
Featured Video
Learn about the 3 core single-use technologies behind Pall's approach to continuous processing in this video from the American Pharmaceutical Review
View All Videos
Technical Papers
Best Practices for Achieving Virus Safety
Lifetime study for JSR Amsphere A3 – protein A resin
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Read All Technical Papers
Featured Products
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
Stronger Tubing Welds – AdvantaPure®
View All Products
